ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2135

Knee Osteoarthritis Pain Is Differentially Associated with Tissue Degradation and Joint Inflammation

Anne C. Bay-Jensen1, Steven B. Abramson2, Jonathan Samuels3, Inger Byrjalsen4, Svetlana Krasnokutsky Samuels5, Tina Manon-Jensen6, Morten Asser Karsdal1 and Mukundan Attur7, 1Rheumatology, Nordic Bioscience, Herlev, Denmark, 2Rheumatology Research, NYU School of Medicine and NYU Hospital for Joint Diseases, New York, NY, 3Department of Medicine, NYU School of Medicine, NYU Langone Medical Center, New York, NY, 4Nordic Bioscience, Clinical Development, Herlev, Denmark, 5Svetlana Krasnokutsky, NYU Hospital for Joint Diseases, New York, NY, 6Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 7Rheumatology Research, NYU - Hospital for Joint Diseases, New York, NY

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Biomarkers, Inflammation, osteoarthritis and pain

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Biology and Pathology of Bone and Joint - Poster I

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Osteoarthritis (OA) is a disease characterized by pain and tissue destruction, in some cases concomitant with inflammation. The link between pain and tissue destruction is yet unknown, and there is a lack objective quantifiable parameters. Collagens are the main structural proteins of the joint extracellular matrix. The degradation of especially type I (connective tissue), II (cartilage), III (synovium) and IV (basement membrane) collagens have been shown to be elevated in OA. So we investigated whether biomarkers reflecting collagen degradation were associated with knee OA representing with different pain and inflammatory phenotypes.

Methods:  111 knee OA patients, 62% women, from NYUHJD progression cohort study with varying degree of OA were included: mean (SD) age, 62 (10); mean(SD) BMI, 27(4); NSAID users, 23%; radiographic OA (KL≥2) 68%; and bilateral knee OA; 87%. Pain was assessed by VASpain and WOMAC at baseline (BL) at a 2-year follow-up (FU) visit. Median (IQR) were 39 (13-69) and 37 (13-52) for BL VASpain and WOMACpain. 4 BL serum biomarkers of type I, II, III and IV collagen degradation (C1M, C2M, C3M, C4M), and the 2 inflammatory biomarkers CRPM and hsCRP, were assessed. Data were log2 transformed. Associations between BL biomarkers, BL pain and change (CHG) pain scores were assessed by multivariate linear model including gender, age, BMI, KLsignal knee, bilateral knee OA and NSAID use. Patients with cont. mild/moderate pain had a BL VASpain<54 and FU VASpain<30, cont. moderate/severe pain had VASpain>30 at baseline and FU, and transitional severe pain had either VASpain_BL<30 and VASpain_FU>54 or VASpain_BL>54 and VASpain_FU<30 (ref). Patients with; low biochemical disease activity index (bDAI) low in CRPM (<12nM) moderate bDAI were high in CRPM but low in hsCRP (<5), and high bDAI (flare) were high in CRPM and hsCRP.

Results:  BL association between pain and biomarkers C2M (β -17.9, p<0.0001) and KLsignal knee (β -5.4, p=0.0031) were significantly associated with WOMAC pain. C2M (β -12.4, p=0.0033), C3M (β -19.9, p=0.059), age (β -0.84, p<0.0018), KLsignal knee (β 8.9, p=0.0021) and bilateral knee OA (β -12.2, p=0.087) were associated with VASpain. Association between BL biomarkers and CHG pain C2M (β 13.3, p=0.0016), age (β 0.5, p=0.029) and bilateral OA (β -12.0, p=0.043) were significantly associated with delta WOMACpain. Only age, BMI and NSAID use was associated with CHG VASpain. Association between pain phenotypes and BL biomarkers Patients with cont. mild/moderate pain had significantly higher C2M compared patients with transitional severe pain (p=0.0014) and cont. moderate/severe pain (p=0.04). Biomarker, BL pain and CHG pain in patients w. inflammatory OA Patient with low bDAI had lower WOMACpain (p<0.05) and VASpain(p<0.1). C1M was higher (p<0.05) in the flare group compared to the low and moderate bDAI groups. C3M was higher (p<0.05) in the moderate bDAI group than the low DAI group.

Conclusion:  Different collagen degradation products are linked differentially to different phenotypes. Cartilage degradation (C2M) was consistently linked to CHG pain phenotypes, whereas it was not associated with an inflammatory phenotype. In contrast, C1M and C3M were linked to inflammatory and flared OA.


Disclosure: A. C. Bay-Jensen, Nordic Bioscience A/, 1,Nordic Bioscience A/S, 3,D-BOARD, 2; S. B. Abramson, None; J. Samuels, None; I. Byrjalsen, Nordic Bioscience A/S, 3; S. Krasnokutsky Samuels, None; T. Manon-Jensen, None; M. A. Karsdal, Nordic Bioscience A/S, 1,Nordic Bioscience A/S, 3; M. Attur, None.

To cite this abstract in AMA style:

Bay-Jensen AC, Abramson SB, Samuels J, Byrjalsen I, Krasnokutsky Samuels S, Manon-Jensen T, Karsdal MA, Attur M. Knee Osteoarthritis Pain Is Differentially Associated with Tissue Degradation and Joint Inflammation [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/knee-osteoarthritis-pain-is-differentially-associated-with-tissue-degradation-and-joint-inflammation/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2016

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-osteoarthritis-pain-is-differentially-associated-with-tissue-degradation-and-joint-inflammation/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology